Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

18 results
Display

Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial

Shim M, Bang WJ, Oh CY, Kang MJ, Cho JS

Purpose: To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination’s effect on functional...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms

Kim YJ, Tae BS, Bae JH

Special considerations should be made when selecting medications for the treatment of lower urinary tract symptoms (LUTS) in older patients especially those over 65 years old. This review summarizes the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neuromuscular blockade reversal with sugammadex versus pyridostigmine/ glycopyrrolate in laparoscopic cholecystectomy: a randomized trial of effects on postoperative gastrointestinal motility

An J, Noh H, Kim E, Lee J, Woo K, Kim H

Background: Acetylcholinesterase inhibitors (e.g., pyridostigmine bromide) are used for neuromuscular blockade (NMB) reversal in patients undergoing surgery under general anesthesia (GA). Concurrent use of anticholinergic agents (e.g., glycopyrrolate) decreases cholinergic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in attention variables in those who treated with anticholinergic agents for nonmonosymptomatic enuresis

Jang G, Im YJ, Suh J, Park K

PURPOSE: Brain dysfunction related to areas regarding attention and arousal may occur not only in patients with attention-deficit/hyperactivity disorder (ADHD) but also in patients with enuresis and daytime symptoms. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacotherapy for chronic obstructive pulmonary disease

Kim IA, Park YB, Yoo KH

The goals of management of stable chronic obstructive pulmonary disease (COPD) are to reduce both current symptoms and future risks with minimal side effects from treatment. Identification and reduction of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis

Motavasseli D, Chesnel C, Charlanes , Menoux D, Charoenwong F, Le Breton , Amarenco G

PURPOSE: To evaluate adherence to anticholinergic therapy (AT) and clean intermittent self-catheterization (CISC) in patients with multiple sclerosis (MS) and to identify factors associated with poor adherence. METHODS: This single-center study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sugammadex use can decrease the incidence of post-operative urinary retention by avoiding anticholinergics: a retrospective study

Cha JE, Park SW, Choi YI, Oh ID, Kang HY, Lee SH, Choi JH

BACKGROUND: Postoperative urinary retention (POUR) is a common complication after total knee arthroplasty (TKA) and associated with the use of anticholinergics. The introduction of sugammadex has decreased perioperative use of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors

Hsiao SM, Liao CH, Lin HH, Kuo HC

PURPOSE: To determine the duration of antimuscarinic therapy for overactive bladder syndrome (OAB) appropriate for assessment of the efficacy of treatment, and to evaluate the possible predictive factors for response...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Outcome in Male Patients With Detrusor Overactivity With Impaired Contractility

Liu S, Chan L, Tse V

PURPOSE: To review the clinical outcomes of patients with voiding dysfunction who have detrusor overactivity with impaired contractility (DOIC) diagnosed with urodynamic studies. METHODS: Urodynamic reports from 2005 to 2009 were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tolterodine to Relieve Urinary Symptoms Following Transurethral Resection of the Prostate: A Double-Blind Placebo-Controlled Randomized Clinical Trial

Tehranchi , Rezaei Y, Shojaee R

PURPOSE: To evaluate the effect of tolterodine on early storage symptoms following transurethral resection of the prostate. MATERIALS AND METHODS: Seventy patients over 55 years of age who underwent transurethral resection...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advance in inhaler medications for chronic obstructive pulmonary disease patients

Oh YM

  • KMID: 2342368
  • J Korean Med Assoc.
  • 2014 Feb;57(2):155-158.
Chronic obstructive pulmonary disease (COPD) is one of the highest ranking diseases with regard to prevalence and mortality in Korea and also worldwide. In the past decade, effective inhaler medications...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Generalized Hyperhidrosis Complicated with Acute Renal Failure

Kim TS, Kang MH, Lim KR, Lee SH, Lee WH, Heo JW, Oh WS

  • KMID: 2264303
  • Korean J Med.
  • 2012 Apr;82(4):497-502.
Hyperhidrosis is a disorder characterized by perspiration in excess of the physiologic amount necessary to maintain thermal homeostasis. It is categorized as either a primary condition or a condition occurring...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Anticholinergics for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Young and Middle-Aged Patients: A Single-Blinded, Prospective, Multi-Center Study

Kim DS, Kyung YS, Woo SH, Chang YS, Kim HJ

  • KMID: 2232813
  • Int Neurourol J.
  • 2011 Sep;15(3):172-175.
PURPOSE: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) exhibits variable lower urinary tract symptoms (LUTS). The aim of this study was to evaluate the incidence of LUTS and the efficacy of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Issues on Safety of Long-Acting Muscarinic Antagonist

Lee YD, Cho Y, Han MS

  • KMID: 2319504
  • Tuberc Respir Dis.
  • 2011 May;70(5):384-389.
The prevention of and the controlling of symptoms, reductions in the frequency of exacerbations, and disease severity are central to the pharmacologic therapy of chronic obstructive pulmonary disease (COPD). COPD...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Low-Dose Propiverine in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia with Storage Symptoms: A Prospective, Randomized, Single-Blinded and Multicenter Clinical Trial

Bae JH, Kim SO, Yoo ES, Moon KH, Kyung YS, Kim HJ

  • KMID: 2315610
  • Korean J Urol.
  • 2011 Apr;52(4):274-278.
PURPOSE: The aim of this study was to evaluate whether low-dose anticholinergics combined with an alpha1-receptor antagonist would continue the effect of an alpha-blocker, decrease the side effects of anticholinergics,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Experience of Combination Therapy with Alpha Adrenergic Receptor Antagonist and Anticholinergic Agent in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: 12 Month Follow-up

Seo YM, Kim HJ

PURPOSE: Through more than 12 months of follow-up, the efficacy and safety of combination therapy with alpha adrenergic receptor antagonist and anticholinergic agent was investigated retrospectively. MATERIALS AND METHODS: This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Stent Position Is More Important than alpha-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study

Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, Yang DY, Lee SK, Cho JS

  • KMID: 2314628
  • Korean J Urol.
  • 2010 Sep;51(9):636-641.
PURPOSE: To evaluate the clinical factors that impact ureteral stent-related lower urinary tract symptoms (LUTS) after ureteroscopic ureterolithotomy, including the stent position and medication. MATERIALS AND METHODS: Fifty-three patients who underwent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet's disease

Kim EH, Mok JW, Bang D, Lee ES, Lee SN, Park KS

Intercellular adhesion molecule-1 (ICAM-1) is expressed on vascular endothelial cells and its expression increases during the inflammatory response in patients with active Behcet's disease (BD). The ICAM1 gene mutations are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr